Shuhei Nagashima
Yokohama, 2410815, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A case of complete remission by cabozantinib as an end-line treatment for advanced hepatocellular carcinoma.
Journal: Clinical journal of gastroenterology
Published: July 31, 2024
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
Journal: International journal of clinical oncology
Published: May 17, 2023
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
Journal: BMC cancer
Published: October 31, 2022
Sarcopenia: Prognostic Value for Unresectable Pancreatic Ductal Adenocarcinoma Patients Treated With Gemcitabine Plus Nab-Paclitaxel.
Journal: Pancreas
Published: April 11, 2022
Nal-IRI/5-FU/LV versus modified FOLFIRINOX and FOLFIRI as second-line chemotherapy for unresectable pancreatic cancer: A single center retrospective study.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: March 21, 2022
Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: A real-world analysis.
Journal: Cancer medicine
Published: October 03, 2021
Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma.
Journal: Molecular and clinical oncology
Published: October 29, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026